如何预测炎症性关节炎患者的药物坚持和其他与健康相关的坚持?
Stéphanie Mussel1, Elisabeth Spitz1, Elise Eby2
1Lorraine University, Inserm, INSPIIRE, Nancy 54000, France.
Patient education and counseling
|February 28, 2026
概括
对治疗的正念技能和信念显著影响炎症性关节炎 (IA) 患者的药物坚持. 接受和承诺疗法 (ACT) 可以改善坚持.
科学领域:
- 类风湿病学 类风湿病学
- 心理学 心理学 心理学
- 健康 行为 健康行为
背景情况:
- 坚持治疗对于管理炎症性关节炎 (IA) 是至关重要的.
- 心理因素显著影响慢性疾病的治疗坚持.
- 了解这些因素可以优化患者的治疗结果.
研究的目的:
- 调查心理变量在IA患者药物坚持中的作用.
- 确定在日常生活和医疗领域的坚持的特定心理预测因素.
- 探索接受和承诺疗法 (ACT) 的潜力,以改善坚持.
主要方法:
- 一组250名IA患者在基线和三个月后完成了在线问卷.
- 通过使用慢性疾病概况 (GACID-P) 的一般依从性来评估依从性.
- 测量了包括焦虑,抑郁,对药物的信仰,心理需求和正念在内的心理变量.
主要成果:
- 正念技能 (观察,有意识地行动,不反应) 预测了两个坚持领域.
- 关于治疗必要性和过度使用的信念预测了医疗遵守.
- 对相关性的丧需要预测日常生活的坚持.
结论:
- 正念技能和治疗信念是提高IA的一般坚持的关键心理因素.
- 在这一群体中,ACT是一种有前途的治疗方法,可以改善药物坚持.
相关概念视频
01:29Inflammatory Bowel Disease IV: Pharmacological Management
862
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
862
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
608
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
608
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
660
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
660
01:28Drug Therapy
331
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
331
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
974
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
974
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
577
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
577